Diagnostic accuracy of upper tract urothelial carcinoma: how samples are collected matters

References

• The Cancer Register of the National Board of Health and Welfare, Statistical Database [Internet]. Stockholm, Sweden: National Board of Health and Welfare; 2014. [cited 2016 Jul 7]. Available from: http://www.socialstyrelsen.se/statistik/statistikdatabas
   Google Scholar
• Greene FL, editor. AJCC cancer staging manual. 6th ed. Philadelphia (PA): Lipincott Raven; 2002.
   Google Scholar
• Jimenez RE, Keane TE, Hardy HT, et al. PT1 urothelial carcinoma of the bladder: criteria for diagnosis, pitfalls, and clinical implications. Adv Anat Pathol. 2000;7:13–25.
   PubMed Web of Science ®Google Scholar
• Xu AD, Ng CS, Kamat A, et al. Significance of upper urinary tract urothelial thickening and filling defect seen on MDCT urography in patients with a history of urothelial neoplasms. Am J Roentgenol. 2010;195:959–965.
   PubMed Web of Science ®Google Scholar
• Grahn A, Melle-Hanna M, Malm C, et al. Diagnostic accuracy of CT urography and visual assessment during ureterorenoscopy in upper tract urothelial carcinoma. BJU Int. 2017;119:289–297.
   PubMed Web of Science ®Google Scholar
• Kumar A, Kumar R, Gupta NP. Comparison of NMP22 bladderchek test and urine cytology for the detection of recurrent bladder cancer. Jpn J Clin Oncol. 2006;36:172–175.
   PubMed Web of Science ®Google Scholar
• Lodde M, Mian C, Wiener H, et al. Detection of upper urinary tract transitional cell carcinoma with immunocyt: a preliminary report. Urology. 2001;58:362–366.
   PubMed Web of Science ®Google Scholar
• Messer J, Shariat SF, Brien JC, et al. Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma. BJU Int. 2011;108:701–705.
   PubMed Web of Science ®Google Scholar
• Keeley FX, Kulp DA, Bibbo M, et al. Diagnostic accuracy of ureteroscopic biopsy in upper tract transitional cell carcinoma. J Urol. 1997;157:33–37.
   PubMed Web of Science ®Google Scholar
• Gupta R, Paner GP, Amin MB. Neoplasms of the upper urinary tract: a review with focus on urothelial carcinoma of the pelvicalyceal system and aspects related to its diagnosis and reporting. Adv Anat Pathol. 2008;15:127–139.
   PubMed Web of Science ®Google Scholar
• Oldbring J, Hellsten S, Lindholm K, et al. Flow DNA analysis in the characterization of carcinoma of the renal pelvis and ureter. Cancer. 1989;64:2141–2145.
   PubMed Web of Science ®Google Scholar
• Blute ML, Tsushima K, Farrow GM, et al. Transitional cell carcinoma of the renal pelvis: nuclear deoxyribonucleic acid ploidy studied by flow cytometry. J Urol. 1988;140:944–949.
   PubMed Web of Science ®Google Scholar
• Murphy WM, Chandler RW, Trafford RM. Flow cytometry of deparaffinized nuclei compared to histological grading for the pathological evaluation of transitional cell carcinomas. J Urol. 1986;135:694–697.
   PubMed Web of Science ®Google Scholar
• Johnson GB, Portela D, Grasso M. Advanced ureteroscopy: wireless and sheathless. J Endourol. 2006;20:552–555.
   PubMed Web of Science ®Google Scholar
• Johnson GB, Fraiman M, Grasso M. Broadening experience with the retrograde endoscopic management of upper urinary tract urothelial malignancies. BJU Int. 2005;95(Suppl 2):110–113.
   PubMed Web of Science ®Google Scholar
• Epstein J, Amin MB, Reuter M. The World Heath Organization/International Society of Urological Pathologists consensus classification of urothelial (transitional cell) neoplasms of urinary bladder. Am J Surg Pathol. 1998;22:1435–1448.
   PubMed Web of Science ®Google Scholar
• Eble JN, Sauter G, Epstein JI, et al. World Health Organization classification of tumors: pathology and genetics of tumours of the urinary system and male genital organs. Lyon, France: IARC Press; 2004.
   Google Scholar
• Cheng L, Lopez-Beltran A, Bostwick DG. Grading of bladder cancer. In: Bladder pathology. Hoboken, NJ: John Wiley & Sons; 2012. p. 161–191.
   Google Scholar
• Williams SK, Denton KJ, Minervini A, et al. Correlation of upper-tract cytology, retrograde pyelography, ureteroscopic appearance, and ureteroscopic biopsy with histologic examination of upper-tract transitional cell carcinoma. J Endourol. 2008;22:71–76.
   PubMed Web of Science ®Google Scholar
• Ooms EC, Anderson WA, Alons CL, et al. Analysis of the performance of pathologists in the grading of bladder tumors. Hum Pathol. 1983;14:140–143.
   PubMed Web of Science ®Google Scholar
• Robertson AJ, Beck JS, Burnett RA, et al. Observer variability in histopathological reporting of transitional cell carcinoma and epithelial dysplasia in bladders. J Clin Pathol. 1990;43:17–21.
   PubMed Web of Science ®Google Scholar
• Schapers RF, Pauwels RP, Wijnen JT, et al. A simplified grading method of transitional cell carcinoma of the urinary bladder: reproducibility, clinical significance and comparison with other prognostic parameters. Br J Urol. 1994;73:625–631.
   PubMedGoogle Scholar
• Coblentz TR, Mills SE, Theodorescu D. Impact of second opinion pathology in the definitive management of patients with bladder carcinoma. Cancer. 2001;91:1284–1290.
   PubMed Web of Science ®Google Scholar
• Murphy WM, Takezawa K, Maruniak NA. Interobserver discrepancy using the 1998 World Health Organization/International Society of Urologic Pathology classification of urothelial neoplasms: practical choices for patient care. J Urol. 2002;168:968–972.
   PubMed Web of Science ®Google Scholar
• Raitanen MP, Aine R, Rintala E, et al. Differences between local and review urinary cytology in diagnosis of bladder cancer. An interobserver multicenter analysis. Eur Urol. 2002;41:284–289.
   PubMed Web of Science ®Google Scholar
• Sharma P, Kini H, Pai RR, et al. Study of the reproducibility of the 2004 World Health Organization classification of urothelial neoplasms. Indian J Pathol Microbiol. 2015;58:59–61.
   PubMed Web of Science ®Google Scholar
• Smith AK, Stephenson AJ, Lane BR, et al. Inadequacy of biopsy for diagnosis of upper tract urothelial carcinoma: implications for conservative management. Urology. 2011;78:82–86.
   PubMed Web of Science ®Google Scholar
• Guarnizo E, Pavlovich CP, Seiba M, et al. Ureteroscopic biopsy of upper tract urothelial carcinoma: improved diagnostic accuracy and histopathological considerations using a multi-biopsy approach. J Urol. 2000;163:52–55.
   PubMed Web of Science ®Google Scholar
• El-Hakim A, Weiss GH, Lee BR, et al. Correlation of ureteroscopic appearance with histologic grade of upper tract transitional cell carcinoma. Urology. 2004;63:647–650.
   PubMed Web of Science ®Google Scholar
• Vashistha V, Shabsigh A, Zynger DL. Utility and diagnostic accuracy of ureteroscopic biopsy in upper tract urothelial carcinoma. Arch Pathol Lab Med. 2013;137:400–407.
   PubMed Web of Science ®Google Scholar
• Yamany T, van Batavia J, Ahn J, et al. Ureterorenoscopy for upper tract urothelial carcinoma: how often are we missing lesions? Urology. 2015;85:311–315.
   PubMed Web of Science ®Google Scholar
• Gillan A, El-Mokadem I, Rai B, et al. Carcinoma in situ is significantly underdetected by prenephroureterectomy ureteroscopy in the management of upper tract urothelial cancers. Biomed Res Int. 2015;2015:547586.
   PubMed Web of Science ®Google Scholar